Back
Sarepta Therapeutics Stock Price Chart
Invest in the Next Big AI Disruptor Today
Learn More
Sell
36
SRPT
Sarepta Therapeutics
Last Price:
124.65
Seasonality Move:
-1.39%
7 Day Trial
ALL ACCESS PASS
$
7
The Fed Just Cut Rates-Here's Alex Green's $1 Million AI Stock Picks
Watch Alex Green's breakdown and discover the next big AI winners!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.
Sarepta Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 125.45 | Sell |
| 20-day SMA: | 127.75 | Sell |
| 50-day SMA: | 135.2 | Sell |
| 200-day SMA: | 127.53 | Sell |
| 8-day EMA: | 125.39 | Sell |
| 20-day EMA: | 128.04 | Sell |
| 50-day EMA: | 132.59 | Sell |
| 200-day EMA: | 128.64 | Sell |
Sarepta Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.18 | Sell |
| Relative Strength Index (14 RSI): | 35.54 | Sell |
| Chaikin Money Flow: | -49995 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (124.27 - 135.95) | Sell |
| Bollinger Bands (100): | (123.89 - 147.49) | Sell |
Sarepta Therapeutics Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sarepta Therapeutics Stock
Is Sarepta Therapeutics Stock a Buy?
- Sarepta Therapeutics share price is 124.53 while SRPT 8-day simple moving average is 125.45, which is a Sell signal.
- The stock price of SRPT is 124.53 while Sarepta Therapeutics 20-day SMA is 127.75, which makes it a Sell.
- Sarepta Therapeutics 50-day simple moving average is 135.20 while SRPT share price is 124.53, making it a Sell technically.
- SRPT stock price is 124.53 and Sarepta Therapeutics 200-day simple moving average is 127.53, creating a Sell signal.
SRPT Technical Analysis vs Fundamental Analysis
Sell
36
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy or a Sell?
-
Sarepta Therapeutics stock is rated a Sell
The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Sarepta Therapeutics Stock Info
Market Cap:
11.88B
Price in USD:
124.53
Share Volume:
756.59K
Sarepta Therapeutics 52-Week Range
52-Week High:
173.25
52-Week Low:
55.25
Sell
36
Sarepta Therapeutics (SRPT)
is a Sell
Sarepta Therapeutics Share Price Forecast
-
What is the Sarepta Therapeutics stock price today?
The Sarepta Therapeutics stock price is 124.53 USD today. -
Will SRPT stock go up or go down?
Sarepta Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Sarepta Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sarepta Therapeutics is overvalued.
Is Sarepta Therapeutics Stock a Buy?
- Sarepta Therapeutics share price is 124.53 while SRPT 8-day exponential moving average is 125.39, which is a Sell signal.
- The stock price of SRPT is 124.53 while Sarepta Therapeutics 20-day EMA is 128.04, which makes it a Sell.
- Sarepta Therapeutics 50-day exponential moving average is 132.59 while SRPT share price is 124.53, making it a Sell technically.
- SRPT stock price is 124.53 and Sarepta Therapeutics 200-day simple moving average is 128.64, creating a Sell signal.
Fundamental Analysis of Sarepta Therapeutics
Is Sarepta Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.
Technical Analysis of Sarepta Therapeutics
Should I short Sarepta Therapeutics stock?
- SRPT Moving Average Covergence Divergence (MACD) indicator is -3.18, suggesting Sarepta Therapeutics is a Sell
- Sarepta Therapeutics Relative Strength Index (RSI) is 35.54, which suggest Sarepta Therapeutics is oversold
- The Bollinger Bands (25) for Sarepta Therapeutics is (124.27 - 135.95), which suggest Sarepta Therapeutics is a Sell
- The Bollinger Bands (100) for Sarepta Therapeutics is (123.89 - 147.49), which suggest Sarepta Therapeutics is a Sell
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.